Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 153-159

Karger

Access to resources Recommend Favorite

Does Advanced Access improve access to primary health care? Questionnaire survey of patients

By Salisbury Chris   Goodall Stephen   Montgomery Alan A   Pickin D Mark   Edwards Sarah   Sampson Fiona   Simons Lucy   Lattimer Val  

British Journal of General Practice, Vol. 57, Iss. 541, 2007-08 ,pp. : 615-621

Royal College of General Practitioners

Access to resources Recommend Favorite

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 753-762

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Band Electrode: Ongoing Experience with a Novel Turp Loop to Improve Hemostasis in 265 Patients

By  

Urologia Internationalis, Vol. 72, Iss. 1, 2004-01 ,pp. : 40-45

Karger

Access to resources Recommend Favorite

Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis

By Higuchi M   Horiuchi T   Kojima T   Nishizaka H   Ishibashi H   Hayashi K   Niho Y   Nagasawa K  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 5, 1998-10 ,pp. : 429-432

Informa Healthcare

Access to resources Recommend Favorite